Isidor Bertrand, Le Cunff Martine, Boceno Michelle, Boisseau Pierre, Thomas Caroline, Rival Jean-Marie, David Albert, Le Caignec Cédric
Service de Génétique Médicale, Centre Hospitalier Universitaire de Nantes, Nantes Cedex 1, France.
Eur J Med Genet. 2008 Nov-Dec;51(6):679-84. doi: 10.1016/j.ejmg.2008.06.004. Epub 2008 Jul 11.
Monosomy 1p36 is one of the most frequent subtelomeric microdeletion syndromes characterized by distinct craniofacial features and developmental delay/mental retardation. Other common symptoms include hypotonia, seizures, brain abnormalities, visual, auditory and heart defects. Neuroblastoma is a rare feature since to our knowledge only two patients with "pure" 1p36 deletion have been described. We report on a child with developmental delay and facial dysmorphy who developed neuroblastoma at 1 month of age. No primary site outside of the liver could be demonstrated and the tumour regressed spontaneously. Standard karyotyping was normal while subtelomeric screening using Multiplex Ligation-dependent Probe Amplification (MLPA) method revealed a constitutional de novo subtelomeric 1p36 deletion. Subsequent Agilent 244K oligonucleotide array-based comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) analysis showed a complex 1p36.3 deletion/duplication rearrangement. Among the best candidate genes predisposing to the development of neuroblastoma located in 1p36, the AJAP1 gene is the only gene present in the duplication while CHD5, TNFRSF25 and CAMTA1 are located outside of the rearrangement. Therefore, a gene-dosage effect involving a gene located in the duplication including AJAP1 might explain the neuroblastoma observed in our patient. The rearrangement might equally interfere with the expression of a gene located outside of it (including CHD5 located 1Mb away from the rearrangement) playing a role in the tumorigenesis. In conclusion, this study illustrates the complexity of such rearrangement characterized by array CGH and strengthens that constitutional 1p36.3 rearrangement predisposes to the development of neuroblastoma.
1p36单体是最常见的亚端粒微缺失综合征之一,其特征为独特的颅面特征和发育迟缓/智力障碍。其他常见症状包括肌张力减退、癫痫发作、脑部异常、视觉、听觉和心脏缺陷。神经母细胞瘤是一种罕见特征,据我们所知,仅报道过两例“单纯”1p36缺失的患者。我们报告了一名发育迟缓且面部畸形的儿童,该儿童在1月龄时患神经母细胞瘤。未发现肝脏以外的原发部位,肿瘤自发消退。标准核型分析正常,而使用多重连接依赖探针扩增(MLPA)方法进行的亚端粒筛查显示存在先天性新发亚端粒1p36缺失。随后的基于安捷伦244K寡核苷酸阵列的比较基因组杂交(CGH)和荧光原位杂交(FISH)分析显示存在复杂的1p36.3缺失/重复重排。在位于1p36的易引发神经母细胞瘤的最佳候选基因中,AJAP1基因是重复区域中唯一存在的基因,而CHD5、TNFRSF25和CAMTA1位于重排区域之外。因此,涉及包括AJAP1在内的重复区域中一个基因的基因剂量效应可能解释了我们患者中观察到的神经母细胞瘤。这种重排同样可能干扰位于其外的一个基因(包括距离重排区域1Mb的CHD5)的表达,该基因在肿瘤发生中起作用。总之,本研究说明了这种以阵列CGH为特征的重排的复杂性,并强化了先天性1p36.3重排易引发神经母细胞瘤的观点。